Skip to content

Eli Lilly LLY Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$72.25B+10.8%$65.18B+9.7%$59.42B+11.6%$53.26B+8.7%$49B+8.8%
$12.4B+12.2%$11.05B+9.6%$10.08B+9.1%$9.25B+3.1%$8.97B+6.6%
$59.84B+10.6%$54.13B+9.7%$49.34B+12.1%$44.01B+9.9%$40.03B+9.3%
82.8%-0.2pp83%0.0pp83%+0.4pp82.6%+0.9pp81.7%+0.4pp
$14.11B+5.8%$13.34B+6.2%$12.56B+6.2%$11.83B+5.6%$11.2B+1.9%
$11.56B+4.2%$11.09B+6.8%$10.39B+6.6%$9.75B+7.0%$9.11B+6.0%
-$397M+30.5%-$571M+0.4%-$573.2M-51.6%-$378.1M+22.1%-$485.1M-122%
$31.13B+21.0%$25.73B+14.3%$22.5B+33.5%$16.86B+24.0%$13.6B+7.3%
$5.85B+14.9%$5.09B+24.4%$4.09B+33.7%$3.06B+22.7%$2.49B+19.3%
$25.28B+22.5%$20.64B+12.1%$18.41B+33.4%$13.8B+24.3%$11.11B+4.9%
35%+3.3pp31.7%+0.7pp31%+5.1pp25.9%+3.2pp22.7%-0.8pp
$28.15+22.7%$22.95+12.3%$20.44+33.6%$15.30+24.5%$12.29+5.0%
$33.17B+19.6%$27.73B+13.6%$24.4B+30.1%$18.75B+21.5%$15.43B+6.8%
45.9%+3.4pp42.5%+1.5pp41.1%+5.9pp35.2%+3.7pp31.5%-0.6pp
$31.13B+21.0%$25.73B+14.3%$22.5B+33.5%$16.86B+24.0%$13.6B+7.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Eli Lilly's revenue?
Eli Lilly (LLY) generated $72.2B in revenue over the trailing twelve months, up 47.4% year over year.
Is Eli Lilly profitable?
Eli Lilly reported $25.3B in net income over the trailing twelve months, a 35.0% net margin.
What is Eli Lilly's earnings per share?
Eli Lilly's diluted EPS over the trailing twelve months is $28.15.
Where does Eli Lilly's income statement data come from?
Every line is extracted from Eli Lilly's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.